Hasil Pencarian (1)
biotech | CAS: 1363853-26-2
In recent years, various extended half-life factor VIII and factor IX preparations have been studied and gained approval. In order to extend half-lives, techniques such as fusion to protein conjugates (Fc part of IgG1 or albumin), chemical modification (PEGyl…
Kategori:
Blood Coagulation FactorsPegylated agents
Target Protein:
Coagulation factor VIII
Waktu Paruh18.6 ± 4.6h after a…
Vol. Distribusi-
Klirens142 ± 33 mL/h on wi…
Genetik
-